###
中国临床研究:2023,36(11):1613-1618
本文二维码信息
码上扫一扫!
甲状腺微小乳头状癌消融治疗的现状及进展
(浙江省肿瘤医院 中国科学院杭州医学研究所,浙江 杭州 310022)
Recent status and advances of ablation for papillary thyroid microcarcinoma
(Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China)
摘要
本文已被:浏览 1652次   下载 358
投稿时间:2023-10-05   网络发布日期:2023-11-20
中文摘要: 随着消融技术的不断发展,消融已成为甲状腺微小乳头状癌(PTMC)的一种新的治疗选择。近年来有多项临床研究探讨各种消融技术治疗PTMC的可行性、安全性和长期疗效。本文针对近期PTMC消融治疗手段及其疗效进行综述,旨在为该疾病的治疗和方案选择提供参考。
Abstract:With the continuous development of ablation technology, ablation has become a new treatment option for papillary thyroid microcarcinoma (PTMC). Numerous clinical studies have been carried out recently to confirm the viability, safety, and long-term effectiveness of different ablation procedures in the treatment of PTMC. In order to give the most up-to-date information and treatment choices for PTMC, this article examines current ablation therapy options for PTMC and their effectiveness.
文章编号:     中图分类号:    文献标志码:A
基金项目:
附件
引用文本:
陈夏怡, 周玲燕, 陈晨, 隋琳, 闫玉琪, 徐栋.甲状腺微小乳头状癌消融治疗的现状及进展[J].中国临床研究,2023,36(11):1613-1618.

用微信扫一扫

用微信扫一扫